A regional white matter atlas was created on our standard template and used to parcellate right and left periventricular (PV), subcortical (SC), and lobar white matter hyperintensity volumes in subject space to compensate for intersubject variation. Four representative slices can be found proceeding from the inferior (top left) to superior (bottom right) direction. 1 Indicates SC frontal; 2, PV frontal; 3, SC temporal; 4, PV temporal; 5, SC parietal; 6, PV parietal; 7, SC occipital. The periventricular occipital lobe is not shown.
The plots along the top row depict the strength of the correlation that total, periventricular (PV), and subcortical (SC) white matter hyperintensity proportion have with clinical measures of cognition and motor skills. The bottom 4 plots are between the white matter hyperintensity proportion of the 4 main lobes of the brain and the clinical measures of cognition and motor skills. G/PS indicates gait and postural stability; G/P/PS, gait, posture, and postural stability; MMSE, Mini-Mental State Examination; UPDRS, Unified Parkinson's Disease Rating Scale.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Murray ME, Senjem ML, Petersen RC, et al. Functional Impact of White Matter Hyperintensities in Cognitively Normal Elderly Subjects. Arch Neurol. 2010;67(11):1379–1385. doi:10.1001/archneurol.2010.280
Copyright 2010 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2010
To investigate the impact white matter hyperintensities (WMH) detected on magnetic resonance imaging have on motor dysfunction and cognitive impairment in elderly subjects without dementia.
Population-based study on the incidence and prevalence of cognitive impairment in Olmsted County, Minnesota.
A total of 148 elderly subjects (65 men) without dementia ranging in age from 73 to 91 years.
Main Outcome Measures
We measured the percentage of the total white matter volume classified as WMH in a priori–defined brain regions (ie, frontal, temporal, parietal, occipital, periventricular, or subcortical). Motor impairment was evaluated qualitatively using the Unified Parkinson's Disease Rating Scale summary measures of motor skills and quantitatively using a digitized portable walkway system. Four cognitive domains were evaluated using z scores of memory, language, executive function, and visuospatial reasoning.
A higher WMH proportion in all regions except the occipital lobe was associated with lower executive function z score (P value <.01). A higher WMH proportion in all regions, but most strongly for the parietal lobe, correlated with higher Unified Parkinson's Disease Rating Scale gait, posture, and postural stability sum (P value <.01). A higher WMH proportion, whether periventricular, subcortical, or lobar, correlated with reduced velocity (P value <.001).
We conclude that executive function is the primary cognitive domain affected by WMH burden. The data suggest that WMH in the parietal lobe are chiefly responsible for reduced balance and postural support compared with the other 3 lobes and may alter integration of sensory information via parietal lobe dysfunction in the aging brain. Parietal white matter changes were not the predominant correlate with motor speed, lending evidence to a global involvement of neural networks in gait velocity.
White matter hyperintensities (WMH) on T2-weighted magnetic resonance imaging (MRI) and T2-weighted fluid-attenuated inversion recovery MRI have been associated with cognitive dysfunction, particularly memory and executive dysfunction, in elderly individuals.1-7 In addition to age-associated cognitive deficits, WMH may also contribute to age-associated impairments in gait and balance.7,8 In 1 recent study, WMH were correlated with both motor and cognitive functions in the same individuals.5
While there has been interest in the relative contribution of periventricular vs subcortical WMH to gait disorders and cognitive impairment,5,9 there has been less attention focused on the lobar distribution of WMH. The goals of the current study were to determine (1) the association between WMH and motor and cognitive deficits in a group of elderly subjects without dementia who were derived from a population-based cohort, (2) how the radial location (periventricular vs subcortical) of the WMH influenced these associations, and (3) how the lobar location of the WMH influenced these associations. We hypothesized that WMH in certain regions (eg, frontal lobe) would have greater impact than WMH in other regions (eg, occipital lobe). Moreover, we hypothesized that periventricular WMH would correlate with motor dysfunction and subcortical WMH would correlate with cognitive dysfunction based on the assumption that periventricular WMH may disrupt action potential propagation in long descending fiber tracts, while subcortical WMH would disrupt propagation in corticocortical fibers.
Subjects were participants in the Mayo Clinic Study of Aging (MCSA), a population-based study on the incidence and prevalence of cognitive impairment in Olmsted County, Minnesota. The institutional review boards at Mayo Clinic and Olmsted Medical Center approved all MCSA procedures. The MCSA participants were randomly selected and invited to undergo subsequent in-person evaluations, as well as neurological and neuropsychological testing. Magnetic resonance imaging has been incorporated into the MCSA since its inception in 2005. A detailed report of design and sampling has been previously published.10 From the total population of 1434 MCSA controls, 436 MCSA participants underwent both quantitative gait testing and MRI as of May 2008. Of these, only subjects who received a consensus committee diagnosis of neurologically normal,11 had a sum of boxes Clinical Dementia Rating score of zero, and had neuropsychological, neurological, and motor examinations performed within 120 days of MRI acquisition were included in the present study. Subjects were excluded if they had potentially confounding diagnoses such as tumor, alcohol, single stroke, or Parkinson disease. The MRIs of subjects were evaluated for artifacts and removed if the quality interfered with image analysis. The final cohort included 148 elderly subjects (65 men) without dementia ranging in age from 73 to 91 years, with a median of 79 years. Their median estimated Mini-Mental State Examination score was 28, with a range from 24 to 30 (Table 1). All subjects gave written informed consent to participate.
Neurological and neuropsychological tests performed by the MCSA10 have been described previously. For this study, 4 cognitive domains were defined using a neuropsychological battery, including Wechsler Adult Intelligence Scale–Revised subtests. The composite standardized z scores were calculated for each subtest and included the subtest score subtracted by the mean and standard deviation from the overall MCSA cohort for that test. The domains included memory (logical memory II and visual reproduction II subtests from the Wechsler Memory Scale–Revised, delayed recall subtest from the Auditory Verbal Learning Test); language (Boston Naming Test, Semantic Fluency Test); visuospatial (picture completion and block design subtests from the Wechsler Adult Intelligence Scale–Revised); and executive function (Trail Making Test Part B and digit symbol subtest from the Wechsler Adult Intelligence Scale–Revised). A global z score was calculated from the average z score of the 10 tests that form the 4 cognitive domains. A regression method was used to derive an estimated Mini-Mental State Examination score from the 38-item Short Test of Mental Status.
Qualitative gait assessment was determined with the modified Unified Parkinson's Disease Rating Scale.12 The motor examination portion of the test was broken into 4 measures: upper sum (speech volume, facial expression, hand tremor at rest, rigidity of neck and arms); lower sum (leg tremor at rest and leg rigidity); gait and postural stability sum with posture; and gait and postural stability sum without posture. A higher postural stability score can be interpreted as impairment in balance, whereas a higher posture score indicates the shoulders are leaning forward in a stooped manner. The possible number of points for the upper sum, lower sum, and gait and postural stability measure with and without posture were 28, 16, 12, and 8 points, respectively (Table 1).
Quantitative gait assessment was measured using a 4.88-m digitized walkway system with embedded pressure sensors (GAITRite; CIR Systems, Havertown, Pennsylvania).13 Gait velocity was measured from the first footfall to the last, in units of centimeters per second. Ambulation time was recorded as the amount of time it took to walk the length of the walkway from initial step to last. The stride length was measured as the average distance between consecutive steps of the left foot while walking the length of the walkway.
All scans were performed at 3 T (GE Signa, Milwaukee, Wisconsin) at the Mayo Clinic, Rochester, Minnesota. The standardized MRI protocol included a sagittal, T1-weighted, 3-dimensional volume magnetization-prepared rapid acquisition gradient-echo (MPRAGE) sequence. Scan parameters include a section thickness of 1.2 mm in the 170 contiguous partitions with a field of view of 26.0 cm × 26.0 cm, 256 × 256 matrix, bandwidth = 31.3 kHz, 8° flip angle, repetition time = 6.6 milliseconds, and echo time = 2.8 milliseconds. An axial, T2-weighted fluid-attenuated inversion recovery scan was acquired with 48 contiguous slices, each 3.0 mm in thickness, field of view = 22 cm × 22 cm, repetition time = 11 000 seconds, inversion time = 2250 milliseconds, echo time = 147 milliseconds, bandwidth = 31.3 kHz, and matrix = 256 × 192.
A white matter (WM) parcellation atlas was manually traced onto a custom T1 template using the program Analyze (Biomedical Imaging Resource, Rochester, Minnesota) by a trained neuroanatomist. A detailed description of the custom template design can be found in Vemuri et al.14 Radial WM parcellation within the 4 lobes of the brain (frontal, temporal, parietal, and occipital) was based on standardized anatomical criteria (Figure 1). The periventricular zone was defined as the region within a boundary drawn halfway between the ventricular lining and the depth of the deepest penetrating sulcus at any point along the circumference of the lateral ventricle. The WM outside of this boundary, which included the WM in the cortical gyri, defined the subcortical zone.
White matter hyperintensities were segmented from normal brain tissue on fluid-attenuated inversion recovery images using an in-house semiautomated image analysis software tool named Histoseg, which produces a binary mask.15 Next, we used tools in the Statistical Parametric Mapping 5 suite,16 as well as custom-built software to assign the identified WMH to specific lobar and radial regions of interest. For each subject, we first coregistered the fluid-attenuated inversion recovery image and its associated binary WMH mask to the MPRAGE image, using a 6- df affine registration. Next, using the unified segmentation17 algorithm in Statistical Parametric Mapping 5, we simultaneously segmented the MPRAGE image into gray matter, WM, and cerebrospinal fluid and computed the discrete cosine transform parameters to spatially normalize the subject images into the space of the custom template. We then applied these inverse discrete cosine transform parameters to the WM atlas, thereby obtaining a set of anatomical atlas labels corresponding to the subject's MPRAGE image. Finally, we used these subject space labels to parcellate the binary WMH masks into the aforementioned segments. We used a hard classification scheme to binarize the segmentation maps produced by Statistical Parametric Mapping 5, whereby each voxel was labeled as gray matter, WM, or cerebrospinal fluid, depending on which of the 3 tissue classes had a higher probability for that voxel. To determine WM volume in each region of interest, the resulting binary WM masks were parcellated into the same regions of interest as the WMH masks. To adjust for intersubject differences in the volume of the WM in each lobe, a derived value WMH proportion (WMHp) was also created to represent the percentage of WM in each lobe that was “at risk.” The WMHp was defined for a given region (x) as the volume of the WMH in a given region of interest (WMHx) divided by the volume of WM in that region of interest (WMx) and multiplied by 100 [ie, WMHp(x) = (WMHx/WMx) × 100]. Using WMHp to evaluate functional impairment controls for variations in brain size across different subjects, eliminating the need to normalize WMH data by total intracranial volume.
Data were analyzed with nonparametric methods when they were not normally distributed. Log transforms were applied for graphic representation of the data. A pairwise multiple comparison was run to test difference of ranks between regional WMHp, with significance set at P < .05. Associations between nonimaging measures and WMH values were examined with Spearman rank order correlations with an a priori significance level set at P < .01.
Subjects’ frontal lobe WM volume (Table 2) tended to be more than double their temporal WM volume (P < .001), about 60% greater than their parietal WM volume (P < .001), and more than triple their occipital WM volume (P < .001). In terms of the percentage of WM tissue at risk, WMHp of the occipital lobe was far greater than that of the other 3 lobes (P < .001). Still, on average a typical subject's parietal WMHp was greater than their temporal or frontal WMHp (P < .01). The WMHp was far greater in the periventricular zone compared with subcortical WMHp (P < .001).
We analyzed the effect of laterality for periventricular vs subcortical regions and for lobar measures. There were no differences between right and left; therefore, we combined the right and left hemisphere data for all subsequent analyses. Where no significant association was found between regional WMHp and cognitive data, the total WMHp correlation and significance value are reported. There was no significant association between Mini-Mental State Examination score and periventricular, subcortical, or total WMHp (R = −0.02; P = .83).
Greater WMHp correlated with worse performance in the executive function domain, with no independent effect of periventricular or subcortical WMHp (Table 3). Lobar distribution of WMHp showed correlations with the executive function domain z score for frontal, temporal, and parietal lobes, but not for the occipital lobe (Figure 2). There was no correlation between digit symbol scores and overall WMHp. In contrast, significant correlations were found with Trail Making Test Part B scores and periventricular, subcortical, and total WMHp. Trail Making Test Part B scores correlated best with frontal (Figure 2), temporal, and parietal lobe WMHp, but not occipital WMHp. Plots of the Spearman rank order correlations between z scores of cognition and regional WMHp (Figure 2) demonstrate a similar pattern of strength. There was no relationship between WMHp and the z scores for memory (R = −0.05; P = .52) or language (R = −0.10; P = .22), but the visuospatial domain showed a trend toward worse performance with greater WMHp (R = −0.16; P = .06).
Gait and postural stability sum scores were significantly correlated with total WMHp, periventricular WMHp, and subcortical WMHp (Table 4). Unified Parkinson's Disease Rating Scale scores of tremor and rigidity split into upper and lower extremity sums were not associated with any of the WMHp variables (R = 0.05; P = .54). In contrast, the total WMHp, periventricular WMHp, and subcortical WMHp correlated significantly with gait and postural stability sum scores (Table 4). There was a correlation between parietal WMHp and gait/postural stability that may account for this finding since there were no significant relationships with other lobar WMHp scores. The addition of the posture score strengthened the correlation globally (Figure 2). Reduced gait velocity (Table 4) correlated with periventricular and subcortical WMHp (P < .001), and velocity was associated with lobar WMHp (P < .001). Shorter stride length correlated with a greater periventricular and subcortical WMHp (P < .001), as did frontal, temporal, and parietal WMHp. The relationship between velocity and stride length with occipital WMHp was not as strong but was significant (P < .005).
In a cohort of 148 community-dwelling elderly individuals without dementia, we investigated whether a relationship exists between WMH load and motor or cognitive impairment. Few studies have investigated the differential impact of lobar, periventricular, and subcortical WMH on functional impairment in neurologically normal individuals.4,18 Of those, only one to our knowledge has evaluated the relationships between WMH volume and both motor and cognitive dysfunction in normal elderly subjects.5 We found that decreases in executive function correlated with a greater WMHp, with the effect driven by a global increase in WMHp, though occipital WMHp correlates did not reach significance. In addition to a role in executive function, WMHp also correlated significantly with gait and posture measures. The strongest relationship we found was between quantitative measures of gait velocity and WMHp. We acknowledge that the sensitivity of cognition and gait assessments may differ; however, the strength of the correlations was consistently greater with gait than cognition. This observation may suggest that the deleterious effects of WMH could impact motor function to a greater extent than cognition. On a note of caution, our reported correlations were statistically significant, but our imaging observations accounted for a small portion of the observed variance in cognitive and gait abnormalities related to WMH.
Increasing WMH volumes have been hypothesized to have an impact on ambulation in older adults,7,19,20 but the mechanism remains to be determined. Our elderly cohort was neurologically normal, and none were diagnosed with Parkinson disease. To our knowledge, our study is the first to examine associations of Unified Parkinson's Disease Rating Scale items with burden of WMH. The strongest relationship we observed with the Unified Parkinson's Disease Rating Scale was between the WMHp in the parietal lobe with gait and postural control with or without posture added. Gait and postural control are important factors for successful aging,21 with balance disturbances and falls being hypothesized to result from the interruption of frontal lobe connections and descending motor fibers.7,22 A recent study evaluating qualitatively graded WMH and posturographic measures of balance found that parieto-occipital WMH were more strongly associated with reduced balance compared with frontotemporal WMH.8 Our study adds new information, suggesting that WMH in the parietal lobe are more directly responsible for reduced balance and postural support compared with the other 3 lobes. We hypothesize that the WM changes alter integration of sensory information via parietal lobe dysfunction in the aging brain.
The relationship between WMHp and motor disturbances was further strengthened by examining a quantitative measure of speed. Walking speed19 or subjective measures of mobility7,20,23 have been used to support the hypothesis that increases in WMH are related to impaired mobility. Regardless of regional involvement, a greater WMHp was strongly associated with reduced gait velocity. Somewhat surprising was the degree to which gait velocity correlated with WMH. It is a widely held view that speed of cognition undergoes the greatest decline with “normal” aging. The relationship between WMHp and gait velocity suggests that age-related abnormalities of WM may have the greatest impact on motor speed. Parietal WM changes were not the predominant correlate with motor speed, lending evidence to a global involvement of neural networks in gait velocity, whereas balance may require less cognitive input and rely more on the somatosensory input into the parietal lobe.
No relationship between the WMHp was observed with z scores of memory or language but a trend was noted for the visuospatial domain, which might reflect an executive function component to visuospatial reasoning. Other studies have reported a relationship between memory and WMH, often in a cohort that included younger individuals and a wider range of cognitive functioning.2,3,6 We attempted to control for these factors by only selecting a neurologically normal elderly cohort with a narrow age range (73-91 years). The observed association between executive function and overall WMHp is consistent with the current literature.2,3,6 A lack of a correlation between executive function and the percentage of WM at risk in the occipital lobe supports the hypothesis that anterior brain regions may play a key role in the decline of executive function. These collective findings provide evidence that age-related decline in cognitive processing speed is in part related to increased prevalence of WM pathology with age. Correlations between WMH and timed measures of executive function, gait, and gait-postural scores support the conclusion that WMH contribute to functional impairment. The selective nature of the functional deficits associated with WMH suggests that the primary effect of WMH is to reduce the efficiency of neuronal signaling. This conclusion is strengthened by the fact that vastly different functional domains—cognition and gait—were affected, with the common theme being processing speed.
Correspondence: Clifford R. Jack Jr, MD, Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (email@example.com).
Accepted for Publication: March 12, 2010.
Author Contributions:Study concept and design: Murray, Dickson, and Jack. Acquisition of data: Murray and Preboske. Analysis and interpretation of data: Murray, Senjem, Petersen, Hollman, Weigand, Knopman, Ferman, and Jack. Drafting of the manuscript: Murray, Preboske, and Jack. Critical revision of the manuscript for important intellectual content: Senjem, Petersen, Hollman, Weigand, Knopman, Ferman, Dickson, and Jack. Statistical analysis: Murray, Weigand, and Jack. Obtained funding: Petersen, Dickson, and Jack. Administrative, technical, and material support: Senjem and Jack. Study supervision: Ferman, Dickson, and Jack.
Financial Disclosure: Dr Petersen is the chair of the Safety Monitoring Committee for Wyeth and Elan and also a consultant for Elan and GE Healthcare. Dr Knopman serves on a Data Safety Monitoring board for Lilly, is an investigator in a clinical trial sponsored by Elan Pharmaceuticals, Baxter Pharmaceuticals, and Forest Laboratories, served as a one-time consultant to GlaxoSmithKline, and is an associate editor of Neurology and receives compensation for his editorial activities. Dr Jack is an investigator in clinical trials sponsored by Baxter and Pfizer and consults for Elan, Lilly, and Pfizer.
Funding/Support: Ms Murray is a candidate for a doctoral degree from the Mayo Graduate School and is funded by the Robert D. and Patricia E. Kern Predoctoral Fellowship. This work is supported by grants P50 AG016574, U01 AG006786, and RO1 AG11378 from the National Institute on Aging and by the Robert H. and Clarice Smith and Abigail van Buren Alzheimer's Disease Research Program. The National Institutes of Health Opus Building Construction grant C06 RR018898 funded the neuroimaging facility.
Additional Contributions: We thank Keith A. Josephs, MD, for advice concerning Unified Parkinson's Disease Rating Scale measures.